Cargando…
Anti-atherosclerotic therapies: Milestones, challenges, and emerging innovations
Atherosclerosis is the main underlying pathology for many cardiovascular diseases (CVDs), which are the leading cause of death globally and represent a serious health crisis. Atherosclerosis is a chronic condition that can lead to myocardial infarction, ischemic cardiomyopathy, stroke, and periphera...
Autores principales: | Hetherington, Isabella, Totary-Jain, Hana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9552812/ https://www.ncbi.nlm.nih.gov/pubmed/36065464 http://dx.doi.org/10.1016/j.ymthe.2022.08.024 |
Ejemplares similares
-
Emerging Anti-Atherosclerotic Therapies
por: Gluba-Brzózka, Anna, et al.
Publicado: (2021) -
40 Years of Percutaneous Coronary Intervention: History and Future Directions
por: Canfield, John, et al.
Publicado: (2018) -
MicroRNAs and the cellular response to rapamycin: Potential role in diagnosis and therapy
por: Totary-Jain, Hana, et al.
Publicado: (2013) -
The future of immunopsychiatry: Three milestones to clinical innovation
por: De Picker, L.J.
Publicado: (2021) -
Indomethacin sensitizes resistant transformed cells to macrophage cytotoxicity
por: Totary-Jain, Hana, et al.
Publicado: (2016)